Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1341 |
| Name of the vaccine | MenCC-BIO |
| Microbe | Bacteria |
| Disease name | Meningococcal disease |
| Name of bacteria | Neisseria meningitidis |
| Type of vaccine | Conjugate |
| Nucleic acid content | DNA |
| Age | 3 months to 19 years |
| Description of the vaccine | Meningococcal serogroup C vaccine developed by Bio-Manguinhos / FIOCRUZ. |
| Name of the manufacturer | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) |
| Name of the manufacturing country | Brazil |
| Year of manufacture | 2020 |
| Clinical Phase status | Clinical - Phase 2, Phase 3 |
| Bacterial strain | Gram-negative diplococcus. |
| Efficacy | NA |
| Vaccine formulation | Lyophilized white powder |
| Dosage | Two to three doses. |
| Mechanism of action | NA |
| Route of administration | NA |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | Aluminium hydroxide |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT02858570 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |